Medication costs are only a piece of the puzzle when clinicians think about health care access, explains Leigh Maria Ramos-Platt, MD.
Italfarmaco S.p.A. today announced a comprehensive update on the regulatory and clinical advancements for givinostat, the company’s drug for the treat ...
Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, will present data from the Phase 1/2 INSPIRE DUCHENNE ...
Shoppers Foundation for Women's Healthtm is now accepting applications for its 2025 Community Grants program, with a plan to give away $1.5M to charitable organizations working to make care more ...
March 3, 2025 /PRNewswire/ — CureDuchenne, a global leader in Duchenne muscular dystrophy (DMD ... in diagnostics and treatment—all in one location, enhancing access to families in Southern ...
HC Bioscience is shutting down after conducting preclinical models for a transfer RNA (tRNA) asset designed to treat ...
March 3, 2025 /PRNewswire/ — CureDuchenne, a global leader in Duchenne muscular dystrophy (DMD) research ... and the latest advancements in diagnostics and treatment—all in one location, enhancing ...
“Health Minute” brings original health care and health policy reporting from the KFF Health News newsroom to the airwaves each week. (3/18) Here's today's health policy haiku: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results